Financhill
Back

Ascendis Pharma AS Stock Predictions

Ascendis Pharma AS Stock Forecast

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 34.4% based on the past 10 years of stock performance.
  • Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Ascendis Pharma AS Stock Undervalued?
    The current Ascendis Pharma AS [ASND] share price is $158.10. The Score for ASND is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma AS Stock Go Up Next Year?

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 34.4% based on the past 10 years of stock performance.

Ascendis Pharma AS Stock Rating

Sell
32
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS overpriced?

  • Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Ascendis Pharma AS Stock Price History

Is ASND stock going to rise?

  • The current trend is moderately bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com

52-Week Data

52-Week High:
183.00
52-Week Low:
111.09

Prediction Charts

Market Cap:
9.6B
Price in USD:
158.10
Volume:
396.9K
Beta:
0.61

Technical Analysis

SMA50:
157.94
SMA100:
147.70
SMA200:
140.08
52-Wk Change:
28.69%

Stock Predictions

  • Is Ascendis Pharma AS stock public?
    Yes, Ascendis Pharma AS is a publicly traded company.
  • What is the Ascendis Pharma AS stock quote today?
    The Ascendis Pharma AS stock price is 158.10 USD today.
  • How to buy Ascendis Pharma AS stock online?
    You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-2 168.00 172.06 183.00 166.96
May-5 175.60 170.74 175.60 169.44
May-6 169.49 162.84 171.46 161.77
May-7 162.31 160.99 164.81 160.01
May-8 161.10 159.39 162.71 156.02
May-9 159.45 151.25 161.39 151.11
May-12 153.41 154.43 158.33 152.45
May-13 155.20 161.52 162.30 154.64
May-14 161.78 157.20 165.26 156.28
May-15 157.14 157.54 159.03 150.89
May-16 155.01 157.60 160.56 154.80
May-19 157.00 160.33 160.38 156.46
May-20 160.34 161.57 162.22 157.70
May-21 160.38 158.10 162.38 157.02

Ascendis Pharma AS Earnings

Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma AS Forecast Revenue Growth

Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.